REVIVA PHARMACEUTICALS HOLDINGS, INC.
Recent Filings
All 395 filings →| Form | Description | Date |
|---|---|---|
| SCHEDULE 13G | — | Mar 25, 2026 |
| SCHEDULE 13D/A | — | Mar 24, 2026 |
| 4 | FORM 4 | Mar 20, 2026 |
| 4 | FORM 4 | Mar 20, 2026 |
| 8-K | FORM 8-K | Mar 19, 2026 |
| 424B5 | FORM 424B5 | Mar 19, 2026 |
| 424B5 | FORM 424B5 | Mar 18, 2026 |
| 8-K | FORM 8-K | Mar 5, 2026 |
| SCHEDULE 13G/A | — | Feb 17, 2026 |
| 8-K | FORM 8-K | Jan 23, 2026 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Patel Purav | — | Purchase | 3,000 @ $4.69 | 43,547 | Nov 18, 2022 |
| Narayan Prabhu | Chief Financial Officer | Purchase | 50,000 @ $1.66 | 100,000 | Sep 30, 2022 |
| Narayan Prabhu | Chief Financial Officer | Purchase | 50,000 @ $1.21 | 50,000 | Jun 30, 2022 |
| Vedanta Associates-R, LP | — | Purchase | 399,000 @ $3.75 | 399,000 | Jun 1, 2021 |
| SAXENA PARAG | — | Award / Grant | 197,500 | 2,121,750 | Dec 14, 2020 |
| Gerber Sander | — | Sale | 50,000 @ $11.51 | 710,000 | Dec 8, 2020 |
| GLAZER CAPITAL, LLC | — | Sale | 367,000 @ $10.88 | — | Dec 8, 2020 |
| GLAZER PAUL J | — | Sale | 261 @ $11.00 | 606,360 | Dec 2, 2020 |
| GLAZER CAPITAL, LLC | — | Sale | 5,362 @ $11.00 | 606,621 | Nov 27, 2020 |
| GLAZER PAUL J | — | Sale | 7,103 @ $10.90 | 617,952 | Nov 23, 2020 |